Clinic laboratories performed automated cholesterol analyses on four control-serum pools of known cholesterol concentration, using the Lieber- 
The variability in automated cholesterol determinations among laboratories due to differences in methodology, standards, and instruments is well recognized (1 ) . In an effort to minimize interlaboratory and intralaboratory variability, the 12 Lipid-Research Clinic (LRC) laboratories used identical methods, standards, and internal control procedures, and were also monitored by the same blind external-surveillance process. The analytical methods and the internal-control procedures have been described in detail in Volume I of the LRC Program "Manual of Laboratory Operations" (2) .
Rigorous adherence to a common protocol was required, to ensure that data gathered during the studies in the various LRC's met prescribed accuracy and precision limits and allowed assessment of interlaboratory and intralaboratory comparability over a long period of time. So that we could assess the accuracy, precision, and comparability of the laboratories, a three-part quality-control program was developed, consisting of an external surveillance program, an internal quality control program, and a split-sample quality-control program.
The results of analyses for cholesterol performed with AutoAnalyzer AAII (Technicon Corp., Tarrytown, N.Y. 10591) instruments by the 12 LRC laboratories for the internal quality-control pools (pools of known cholesterol concentration) during the first two years of operation are presented in this communication.
Materials and Methods

Primary Standards
The purity of commercial preparations of cholesterol was tested by the Lipid Standardization Laboratory of serum calibration pool as follows: CDC by thin-layer and gas-liquid chromatography and spectrophotometry (3) . The cholesterol was used to prepare sets of solutions of different concentrations in isopropanol (0.50, 1,00, 2.00, 3.00, and 4.00 g/liter) for distribution to LRC laboratories if the purity was equal to the purity of National Bureau of Standards reference cholesterol (99.9%).
Cholesterol Analysis with the AAII
The procedures used by the LRC laboratories for cholesterol analysis have been described in detail (2) . All analyses were performed on 20-fold diluted (as compared to the sample volume) isopropanol extracts of the samples. The extracts were treated with a zeolite mixture to remove interfering substances and then analyzed with the AAII. Standards prepared in isopropanol/water (95/5 by vol) were similarly treated. For the cholesterol analyses on the AAII, the Liebermann-Burchard reaction was used. Samples were analyzed at a rate of 50 samples/h with an 8/1 sample! wash ratio. The linearity of the instrumental response to standards was evaluated by running an ascending series of standards (1.00-4.00 a/liter) at the beginning of each day's run. Recorder response was adjusted to 60% of full-scale deflection with a 3.00 g/liter standard and readjusted after every sample tray (40 samples) to compensate for baseline drift and scale expansion. Results were printed on a digital printer tape. Duplicate extracts of a serum calibrator were always included in the first tray of samples in each day's run.
Calibration of the AAII
On a molar basis, cholesterol esters develop more color with the Liebermann-Burchard reaction than does unesterified cholesterol (4) . Since 60-70% of the cholesterolin human plasma is esterified, and the analytical procedure used does not include hydrolysis of the cholesterol esters, the apparent cholesterol concentrations are falsely high when referred to unesterifled cholesterol standards. It was therefore necessary to use a calibration procedure to correct AAII-assayed cholesterol values so that they corresponded to AbellKendall cholesterol values (5) .
The calibration procedure used daily in the LRC laboratories has been described in detail (2) . The rationale for and validation of the serum calibration technique will be described separately (manuscript in preparation).
Briefly Before the run was continued, the following two criteria had to be met for that run: (a ) the instrument response to standards had to be linear, and (b) the response of the serum calibrator relative to the standards had to be within control limits.
Analysis of Control Pools and Serum Calibrator Pools
A total of four serum pools of known cholesterol content was analyzed by all LRC laboratories during 24 months;two pools were analyzed daily in any one penod. These pools were used for bench control of cholesterol measurements.
The pools were prepared by the Lipid Standardization Laboratory at the CDC, from sterile human sera. Cholesterol-rich lipoprotein fractions, made from a part of the collected human sera, were added to other aliquots of the pooled human sera to make serum poois of different cholesterol concentrations (6) . The pools were then dispensed into glass Wheaton vials. The vials were sealed and stored frozen in an upright position at -20 #{176}C, and tested for homogeneity by automated cholesterol analysis of samples randomly selected from the entire pool. Homogeneous pools were subsequently labeled with a reference value (target value) by replicate analyses performed by the method of Abell et al. (5) . The precision of the determinations was such that the width of a 95% confidence interval was less than 1% of the target value. Frozen aliquots were mailed to the LRC laboratories and stored at -15 o until analyzed. Additional serum pools (SERCAL) were used as AAII calibrators. Calibrator pools were prepared from pooled human sera and labeledby the method of Abell et al. (5) . The precision of the calibrator determinations was such that the width of a 95% confidence interval was less than 0.5% of the target value. The control pools were monitored quarterly for stability during the period of their use, and the calibrator pools were monitored weekly by analyses with the reference method of Abell et al. (5) .
Standardization of Lipid Determinations
Each of the LRC laboratories met the requirements of a lipid standardization program before becoming operational.
Phase I of the program, the evaluation phase, consisted of the analysis of three pools of unknown and two pools of known cholesterol concentration. Six analyses were performed on samples from each pool in each of four runs during two to four weeks. A single analysis was performed on each sample. Any <7.00 <8.00 <9.00 <10.00 target value problems related to the analysis were identified and resolved before proceeding with Phase II.
Phase II, the standardization phase, was a more intensive evaluation of the laboratory's performance.
Its purpose was to determine precision and accuracy more thoroughly and to document that analyses remained stable over a longer period of time. Three sets of frozen serum samples (a total of 320 samples with unknown cholesterol concentrations)
were analyzed on 32 different days, over a period of 8 to 16 weeks. During this time, results had to be within acceptable limits of accuracyand precision. Upon satisfactory completion of Phase II, the laboratory was designatedas "standardized" and permitted to start analyses on LRC specimens. Table 1 summarizes the criteria used for standardization.
The data reported in this communication were collected after all laboratories were standardized.
Subsequent to being standardized, 24 unknown samples were analyzed each month for the duration of the program (Phase III). Six samples were analyzed in one run each week for four weeks of the month. During this surveillance phase, laboratories meeting the criteria specified in Table   1 were redesignated annually as "standardized."
All 12 LRC laboratories remained standardized during the first two years of internal stirveillance reported in this communication.
Data and Results
Data Source
Four samples from each of two serum pools of known cholesterol content were analyzed in each day's run made by an LRC laboratory. Before using a pool for quality control, the laboratory established its own internal quality-control limits for the pool (2) . At the end of each run, the results of the four sample determinations on a pool were examined in relation to these internal limits, to determine whether the day's run was acceptable ("in control"). Samples from an "out of control" run were reanalyzed.
The internal quality-control data (data from pools of known cholesterol content) were collected from each instrument from the initial date of operation. Early data, tabulated before standardization, primarily reflect startup difficulties. The results reported here are based upon data collected from each instrument's first run in Phase III of standardization through the end of December 1974. The first Phase III run was made on March 8, 1973 . The "Red" and "Blue" pools (named after the colors of the vials' caps) were the initial pools used throughout the LRC Program; then the "Qi" and "Q2" pools were phased in, beginning in September 1973,as the samples from the "Red" and "Blue" pools were exhausted. The time period of overlap between the two sets of pools ranged from zero to three months. The results presented here are based on all quality-control data from all runs at all laboratories except for extreme outliers from runs declared "out of control" by a laboratory.
Systematic Differences from Target Value
The very accurate manual Abell-Kendall (MAK) "target values" established by CDC permit examination of the data for both systematic and random error sources.
Systematic errors were measured by a bias statistic, i.e., the difference between an average and the target value; the magnitude of random errors was measured by a variance or standard deviation. Systematic errors may arise from three sources: type of instrument, mdividual instruments, and serum pools.
Systematic Type of instrument Bias
The first line of Table 2 summarizes the average biasesexhibited by the AAII instruments for the four quality-control pools. Except for the Blue pool, the average AAII biases are negative, indicating lower-thantarget-value determinations, on the average. The "% Deviation" column contains averages of percent deviations, defined as:
The percent deviation column shows the AAII instruments averaged 1.3% below target values. The standard errors in Table 2 are quite small, primarily as a result of the large sample sizes, and indicate that the biases are estimated with a high degree of precision. Also, except for results for the Blue pool, the bias estimates are all significantly different from zero.
individual Instrument Biases Table 2 also contains bias estimates and their standard errorsfor each instrument and pool combination and for percent deviation averaged over pools for each instrument. These results are plotted in Figure 1 . Small individual biases, which varied from pool to pool, were observed for each instrument.
For the Red pool (target value = 1.66 gfliter), the biases ranged from -26 to +19 mg/liter, a range of 45 mg/liter about the all-AAII average of -11 mg/liter. The Qi pool (target value = 1.71 g/liter) exhibited more negative biases
Tab)e 2.
Over11
Sla. The average (over pools) percent deviations ( Table  2) vary from -2.0 to -0.5%, a range of 1.5%. The instruinent with the largest average negative bias, number 9, is 0.7% below the all-AAII average of -1.3% and the instrument with the largest average positive bias, Number 10, is 0.8% above the average.
Serum Pool Biases
The AAII results reveal strikingly clear pool-related biases; the Blue pool resulted in the most positive biases (averaging very close to zero for all AAII's combined), followed in order by the Red, Qi, and Q2 pools. There is only one exception to this ordering: the instrument 9 bias of the Red pool is 3 mg/liter more positive than the Blue pool bias. The two sets of pools (Red, Blue vs. Q1, Q2) exhibited different levels of bias.
The percents bias in the Red and Blue pools were -0.66 and +0.08%, and the percents bias in the Qi and Q2 pools were -1.34 and -1.67%. ester ratios in the different control pools) may have been detected as a consequence of the large number of replicate analyses used to estimate the bias of each pool.
At the same time that the Q1 and Q2 pool target values were set, the target value of the "SER 299" serum calibrator pool (a pool used to calibrate the AAII ma- 
Random Variability
Nested analysis of variance estimates (7) of between-run and within-run variance components were computed separately for each pool-instrument cornbination ( Table 3 ). The same analysis was applied to the percent deviation variable, defined in the preceding section, which included results from all four pools. The "SV" column in Table 3 indicates the source of variation (as used in ANOVA tables), Lines identified as "Between Runs" contain statistics related to runto-run variability. Lines identified as "Within Run" contain within-run variability statistics. "Total" lines are explained below. The "df" column refers to the degrees of freedom for each source of variation, as would be found in an ANOVA table. A large "dl" indicates great statistical precision of the estimates of the standard deviations. Table 3 presents three standard deviations, the square roots of the corresponding variance components, for each instrument-pool combination.
The "withinrun" standard deviation estimate is the pooled (over runs) estimate of within-run variability, i.e., a measure of the variability among the four essentially identical samples in one run. The "between-runs" standard deviation estimate is a measure of run-to-run variability. The "total" standard deviation is the square root of the sum of the "between runs" and "within runs" variance components and is an estimate of the standard deviation of a single determination of a quality-control sample from the specified instrument and pool. The "Variance Component %" column indicates the relative magnitudes of the between-runs and within-runs vanance components; the "Variance Component %" is computed at 100 X (VCtT'VC) where VC is the betweenor within-run component and TVC is the "Total" variance components.
Total Variances and Standard Deviations
Better precision over the four pools was consistently observed for AAII Instruments 5, 9, and 11 than for the other AAII's. Poor precision with the Blue pool was observed for Instrument 1. However, only six runs were made with the pool, and the large total standard deviation estimate may have been due to poor statistical precision resulting from few degrees of freedom. Very good precision was generally achieved with all AAII instruments.
Most of the total standard deviations are less than 40 mg/liter.
One expects the precision (standard deviation) of an instrument to be smaller for pools with lower cholesterol concentrations.
As shown in Table 3 , 12 of 13 instruments had smaller total standard deviations for the Qi pool (target value = 1.71 g/liter) than for the Q2 pool (target value 2.51 g/liter), and 7 of 11 instruments had smaller total standard deviations for the Red (1.66 g/ liter) than for the Blue (2.63 g/liter) pool. The Red and Blue pools were used simultaneously and, at later dates, the Qi and Q2 pools were used simultaneously.
Comparison ofresults from the Red and Qi pools or the Blue and Q2 pools would not be appropriate, because widely different dates are involved.
Overall, of 50 CV's for instrument-pool combinations shown in Figure 2 , none had a total CV greater than 3.0%, 11 had total CV's between 2.0% and 3.0%, and 39 had total CV's of 2.0% or lower. All 13 instruments had a total CV of less than 2.0% for the Q2 pool and eight of 12 had total CV's of less than 2.0% for the Qi pool.
Within-Run Variability
The within-run standard deviation estimates are summarized in Table 3 in lines labeled "Within Run," in the "SV" column.
The within-run standard deviations tend to follow the same pattern as the total standard deviations. All instruments performed well with all pools with the possible exception of instrument 1 on the Red and Blue pools. Again, this is probably due to the small sample sizes. For the Blue and Q2 pools (target values 2.63 and 2.51 g/liter, respectively) the within-run standard deviations generally fell in the 20 to 33 mg/liter range. Similar results were observed for the Red pool (target value = 1.66 mg/liter). For the Qi pool, the within-run standard deviations were generally less than 25 mg/ liter.
Between-Run Variability
The standard deviations representing run-to-run variability are shown in the "Between Runs" lines of Table 3 . Between-run standard deviations follow the same pattern as the within-run and total standard deviations. Small run-to-run variability was generally observed with all four quality-control pools on all AAII instruments.
Instrument Comparability
The results of a nested variance components analysis in which data from all AAII instruments were pooled for analysis are presented in Table 4 . These results confirm the conclusions drawn above. The within-run variance components of AAII's are comparable for all pools. Similar conclusions apply to the "Between Runs" variance components.
The total AAII standard deviation for all instruments is 30 to 40 mg/liter. Only 8 to 15% of this variation is due to differences between instruments.
Most of the vanability occurs within and between days on a single instrument. The variability was presumably due to the different batches of reagent and tubing as well as slight changes in instrument response.
Trends
Short-term trends. Short-term trending can be examined through autocorrelations. Lag 1, lag 2, lag 3, and lag 10 autocorrelations were computed from daily means for each instrument/pool combination. A "lag d" correlation is the correlation between values "d" days apart. A high "lag d" correlation indicates that if a machine is high on a given day, it also tends to be high "d" days later. The mean of all available data was calculated for each instrument/pool combination. A "high series" was then defined to be that number of consecutive runs for which the daily run mean was greater than the instrument's overall mean for the pool. Similarly, a "low series" was defined as the number of consecutive runs below the instrument's overall mean for the pool. If there were no trending, the probability that a given run's mean would fall above (below) the instrument mean would be very close to 'h, independent of the results of any previous run. The probability of two consecutive high (low) runs would be (1, 4) trend by the instrument. Table 6 contains a summary of the distribution of lengths of series for low and high series combined. The first column of the table indicates the length of the series, in runs. Lengths greater than 10 runs have been grouped into four groups: 11-20, 21-30, 31-40, and 41-50 runs. In addition, statistics were compiled for "long series," defmed here as any series more than nine runs long. The second column of Table 6 presents the theoretical frequencies, in percentages, for non-trend situations. The instruments are known to experience trends; the theoretical non-trend frequencies are simply presented as a baseline for comparison.
When results for all instruments and pools are cornbined, ignoring whether a series is high or low, the percentage of one-run "series" is very close to 50%, the theoretical non-trend value. The frequencies of series of lengths 3-10 are also reasonably close to the theoretical non-trend values. But only 22.0% of the series were of length two runs, compared to 25% theoretical non-trend, and the frequencies of longer series are substantially higher than one would expect in a nontrend situation, i.e., the results reflect a tendency to trend by some of the instruments. Examination of results for individual instruments, too voluminous to be shown here, verifies the interpretation given above for the most of the instrument/ pool combinations. Two instruments had no long series: AAII Instrument 5 had no series longer than six runs in a series of 94 total runs, and AAII Instrument 8 had no series longer than nine runs in a total of 84 runs. (In both cases the total numbers of runs are counted separately for different pools, so the actual number of analytical runs is about half the number given.) On the other end of the distribution a few instruments had some very long series. As shown in Table 7 , AAII Instruments, 2, 6, and 10 exhibited long-term trends, more or less equally divided between high and low series.
Discussion
Previous surveys have demonstrated that methodology, standardization technique, type of standard, reagent source, and the quality of control sera affect the accuracy and precision of interlaboratory cholesterol measurements (8, 9) and that interlaboratory performance is significantly improved when a common standardization material is used (9) . The LRC laboratories attempted to minimize bias and variability of cholesterol analyses by establishing procedures whereby all participating laboratories used identical instrumentation, aliquots of common primary standard solutions, aliquots of common bench control serum pools, and, for cholesterol analyses performed with the Liebermann-Burchard reaction, common serum calibration pools. The cholesterol concentrations of the bench control poois and the serum calibrator pools were established by reference methodology. The LRC laboratories also used the same sequence of standads and common procedures for instrument start-up, instrument calibration, and analysis. The average cholesterol bias for the 12 laboratories was -1.3% and ranged from -0.5 to -2.0%. The degree of bias varied from pool to pool, ranging from -1.67% on the Q2 pool to +0.08% on the Blue pool. The small individual biases exhibited were revealed only by the many analyses performed. The small but definite average negative bias may be due in part to inherent chemical and physical differences in the measurement of cholesterol by the reference method and automated systems, in part to the variability of the reference method itself, and in part to the small changes in physical properties that may occur in reference sera as they age.
Surprisingly, the run-to-run variance components observed for the LRC cholesterol analyses compared favorably with the within-run variability. Many factors can significantly affect an instrument between runs, but typically they can have only a minor or negligible effect within the course of a run. The converse is not true: virtually any factor that can affect instrument precision within a run can also affect it between runs. As a consequence, run-to-run variance components are frequently substantially larger than within-run components. However, the results in Table 3 show that runto-run variability was tightly controlled for most of the instrument/pool combinations, since the run-to-run variability was less than 50% of the total (i.e., less than the within-run variability) in many cases. This surprisingly good control of run-to-run variability was attributed to strict adherence to analytical protocol.
Even more impressive than the small run-to-run variability is the small instrument-to-instrument variability ( Table 4 ). The AAII instrument-to-instrument variability was substantially smaller than the average within-run and among-run sample-to-sample variability for every quality-control poo1. This demonstrates impressive comparability among instruments and enables cholesterol results from the various laboratories to be pooled in the collaborative study.
The small lag correlations between every tenth run (lag 10) indicate that trend problems were corrected quickly. Runs 10 days apart are only slightly correlated.
Cycles of different lengths within the allowable quality-control limits can be detected by inspection of the LRC laboratory quality-control charts. Individual instruments showed different tendencies toward trends, with great variability in the duration of a cycle and some variability in the distance from the overall mean. This tendency to cycle is also exhibited in the distribution of series of runs of various lengths (Table 5) . One-run series occurred in approximately the non-trend frequency. Series of length 2 occurred less often than expected in a non-trend situation and series of length greater than 9 occurred more often than expected. possible explanation for this observed pattern is the following: when an instrument is operating very close to the overall mean, the runs occur in approximately the theoretical non-trend frequencies, but as an instrument's bias swings on either side of zero the series tend to get longer, interrupted from time to time by a single daily mean on the other side of the long-term mean. These occasional single "other side" daily means terminate the series which is on the same side as the bias and increase the frequency of one-run series. Thus, over a long period of time, the one-run series have approximately the non-trend frequency, but the two-run series occur less frequently, being replaced by longer series.
As noted earlier, trending or cycling is almost unavoidable with these instruments, because of batchto-batch variation in tubing and reagents. One objective of our quality-control program was to maintain bias and precision of the instruments within preset limits so that the effect of cycling was minimized.
The overall results reported here indicate that a high degree of accuracy, precision, and interlaboratory comparability were achieved through the rigorous standardization and control of the entire analytical procedure in the LRC laboratories. Interlaboratory and intralaboratory variability were probably as good as can be achieved with the AAII system. In addition, the average bias was very small and probably approaches the practical limits of accuracy that can be achieved in any collaborative multilaboratory study. More generally, the results show that collaborative studies involving laboratories across the country can be done in a such a way that resulting data can be legitimately pooled for analysis. Care must be taken in standardizing methodology, standards, control pools, calibration material, etc. Internal and external quality-control programs should also be implemented, so that one can monitor and assess the performance and comparability of the various laboratories.
